Global Nuclear Medicine/Radiopharmaceuticals Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 166689
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Nuclear Medicine/Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nuclear Medicine/Radiopharmaceuticals size is estimated to be xx million in 2020 from USD 5593 million in 2019, with a change of XX% between 2019 and 2020. The global Nuclear Medicine/Radiopharmaceuticals market size is expected to grow at a CAGR of 7.8% for the next five years.

Market segmentation

Nuclear Medicine/Radiopharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Diagnostic

Therapeutic

Market segment by Application can be divided into

Oncology

Thyroid

Cardiology

The key market players for global Nuclear Medicine/Radiopharmaceuticals market are listed below:

China Isotope & Radiation

Dongcheng

Jaco

Ciaeriar

Advanced Molecular-imaging Solution

Shanghai Atom Kexing

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Nuclear Medicine/Radiopharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Diagnostic

1.2.3 Therapeutic

1.3 Market Analysis by Application

1.3.1 Overview: Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.4 Global Nuclear Medicine/Radiopharmaceuticals Market Size & Forecast

1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales in Value (2016-2026))

1.4.2 Global Nuclear Medicine/Radiopharmaceuticals Sales in Volume (2016-2026)

1.4.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)

1.5 Global Nuclear Medicine/Radiopharmaceuticals Production Capacity Analysis

1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Total Production Capacity (2016-2026)

1.5.2 Global Nuclear Medicine/Radiopharmaceuticals Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Nuclear Medicine/Radiopharmaceuticals Market Drivers

1.6.2 Nuclear Medicine/Radiopharmaceuticals Market Restraints

1.6.3 Nuclear Medicine/Radiopharmaceuticals Trends Analysis

2 Manufacturers Profiles

2.1 China Isotope & Radiation

2.1.1 China Isotope & Radiation Details

2.1.2 China Isotope & Radiation Major Business

2.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product and Services

2.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.2 Dongcheng

2.2.1 Dongcheng Details

2.2.2 Dongcheng Major Business

2.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Product and Services

2.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.3 Jaco

2.3.1 Jaco Details

2.3.2 Jaco Major Business

2.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Product and Services

2.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.4 Ciaeriar

2.4.1 Ciaeriar Details

2.4.2 Ciaeriar Major Business

2.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product and Services

2.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.5 Advanced Molecular-imaging Solution

2.5.1 Advanced Molecular-imaging Solution Details

2.5.2 Advanced Molecular-imaging Solution Major Business

2.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product and Services

2.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.6 Shanghai Atom Kexing

2.6.1 Shanghai Atom Kexing Details

2.6.2 Shanghai Atom Kexing Major Business

2.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product and Services

2.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

3 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer

3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Nuclear Medicine/Radiopharmaceuticals

3.4 Market Concentration Rate

3.4.1 Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share

3.4.2 Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share

3.5 Global Nuclear Medicine/Radiopharmaceuticals Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Nuclear Medicine/Radiopharmaceuticals Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Region

4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Region (2016-2026)

4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2026)

4.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026)

4.3 Europe Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026)

4.4 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026)

4.5 South America Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026)

4.6 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Type (2016-2026)

5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2026)

5.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Application (2016-2026)

6.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2026)

6.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2026)

7.2 North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2026)

7.3 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Country

7.3.1 North America Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Country (2016-2026)

7.3.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2026)

8.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2026)

8.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Country

8.3.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Country (2016-2026)

8.3.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2026)

9.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2026)

9.3 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Size by Region

9.3.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2026)

10.2 South America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2026)

10.3 South America Nuclear Medicine/Radiopharmaceuticals Market Size by Country

10.3.1 South America Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Country (2016-2026)

10.3.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2026)

11.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2026)

11.3 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Size by Country

11.3.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Nuclear Medicine/Radiopharmaceuticals Typical Distributors

12.3 Nuclear Medicine/Radiopharmaceuticals Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type, (USD Million), 2021-2026

Table 2. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application, (USD Million), 2021-2026

Table 3. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors

Table 4. China Isotope & Radiation Major Business

Table 5. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 6. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Dongcheng Basic Information, Manufacturing Base and Competitors

Table 8. Dongcheng Major Business

Table 9. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 10. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Jaco Basic Information, Manufacturing Base and Competitors

Table 12. Jaco Major Business

Table 13. Jaco Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 14. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Ciaeriar Basic Information, Manufacturing Base and Competitors

Table 16. Ciaeriar Major Business

Table 17. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 18. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors

Table 20. Advanced Molecular-imaging Solution Major Business

Table 21. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 22. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Shanghai Atom Kexing Basic Information, Manufacturing Base and Competitors

Table 24. Shanghai Atom Kexing Major Business

Table 25. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 26. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2019-2021e) & (K Units)

Table 28. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 29. Market Position of Manufacturers in Nuclear Medicine/Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 30. Global Nuclear Medicine/Radiopharmaceuticals Production Capacity by Company, (K Units): 2020 VS 2021

Table 31. Head Office and Nuclear Medicine/Radiopharmaceuticals Production Site of Key Manufacturer

Table 32. Global Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021e) & (K Units)

Table 33. Global Nuclear Medicine/Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)

Table 34. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)

Table 35. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)

Table 36. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 37. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 38. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2021e) & (USD Million)

Table 39. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2021-2026) & (USD Million)

Table 40. Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2016-2021e) & (USD/Unit)

Table 41. Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2021-2026) & (USD/Unit)

Table 42. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 43. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 44. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2021e) & (USD Million)

Table 45. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2021-2026) & (USD Million)

Table 46. Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2016-2021e) & (USD/Unit)

Table 47. Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2021-2026) & (USD/Unit)

Table 48. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)

Table 49. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)

Table 50. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 51. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 52. North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 53. North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 54. North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 55. North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 56. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)

Table 57. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)

Table 58. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 59. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 60. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 61. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 62. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 63. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 64. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021e) & (K Units)

Table 65. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)

Table 66. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)

Table 67. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)

Table 68. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 69. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 70. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 71. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 72. South America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)

Table 73. South America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)

Table 74. South America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 75. South America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 76. South America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 77. South America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 78. South America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 79. South America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 80. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)

Table 81. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)

Table 82. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 83. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 84. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 85. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 86. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 87. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 88. Direct Channel Pros & Cons

Table 89. Indirect Channel Pros & Cons

Table 90. Nuclear Medicine/Radiopharmaceuticals Typical Distributors

Table 91. Nuclear Medicine/Radiopharmaceuticals Typical Customers

List of Figures

Figure 1. Nuclear Medicine/Radiopharmaceuticals Picture

Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 3. Diagnostic

Figure 4. Therapeutic

Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 6. Oncology

Figure 7. Thyroid

Figure 8. Cardiology

Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. United States Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 12. Canada Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 13. Mexico Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 14. Germany Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 15. France Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 16. United Kingdom Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 17. Russia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 18. Italy Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 19. China Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 20. Japan Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 21. Korea Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 22. India Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 23. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 24. Australia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 25. Brazil Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 26. Egypt Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 27. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 28. South Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 29. Turkey Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 30. Global Nuclear Medicine/Radiopharmaceuticals Sales (2016-2026) & (K Units)

Figure 31. Global Nuclear Medicine/Radiopharmaceuticals Production Capacity (2016-2026) & (K Units)

Figure 32. Global Nuclear Medicine/Radiopharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021

Figure 33. Nuclear Medicine/Radiopharmaceuticals Market Drivers

Figure 34. Nuclear Medicine/Radiopharmaceuticals Market Restraints

Figure 35. Nuclear Medicine/Radiopharmaceuticals Market Trends

Figure 36. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2020

Figure 37. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2020

Figure 38. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 39. Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020

Figure 40. Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020

Figure 41. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 42. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2016-2026)

Figure 43. North America Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 44. Europe Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 45. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 46. South America Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 47. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 48. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 49. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2016-2026)

Figure 50. Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)

Figure 51. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 52. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2016-2026)

Figure 53. Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2016-2026) & (USD/Unit)

Figure 54. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 55. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 56. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 57. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 58. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 59. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 60. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 61. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 62. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 63. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2016-2026)

Figure 64. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 65. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 66. South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 67. South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 68. South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 69. South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 72. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 73. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 74. Sales Channel: Direct Channel vs Indirect Channel

Figure 75. Methodology

Figure 76. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz